Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-035082
Filing Date
2020-07-30
Accepted
2020-07-31 11:29:29
Documents
73
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rare-10q_20200630.htm   iXBRL 10-Q 3356068
2 EX-10.1 rare-ex101_380.htm EX-10.1 336444
3 EX-10.2 rare-ex102_378.htm EX-10.2 21898
4 EX-10.3 rare-ex103_379.htm EX-10.3 70125
5 EX-31.1 rare-ex311_6.htm EX-31.1 17449
6 EX-31.2 rare-ex312_10.htm EX-31.2 17450
7 EX-32.1 rare-ex321_9.htm EX-32.1 10871
8 GRAPHIC gtyma5rk5bl0000001.jpg GRAPHIC 40735
9 GRAPHIC ggdj1gd10413000001.jpg GRAPHIC 40735
10 GRAPHIC gyqa33wcgkxq000001.jpg GRAPHIC 51413
  Complete submission text file 0001564590-20-035082.txt   10761313

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA rare-20200630.xsd EX-101.SCH 63008
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rare-20200630_cal.xml EX-101.CAL 51765
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rare-20200630_def.xml EX-101.DEF 167440
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE rare-20200630_lab.xml EX-101.LAB 388111
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rare-20200630_pre.xml EX-101.PRE 305096
16 EXTRACTED XBRL INSTANCE DOCUMENT rare-10q_20200630_htm.xml XML 1996598
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

EIN.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 201064548
SIC: 2834 Pharmaceutical Preparations